Antithrombogenic effects of calcium channel blockers: Synergism with prostacyclin and thromboxane synthase inhibitors

Thrombosis Research

Volumn 34, Issue 5, 1984, Pages 367-378

  Onoda, James M ^a   Sloane, Bonnie F ^a   Honn, Kenneth V ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

calcium antagonists; Platelets; thromboxane A2

Indexed keywords

CALCIUM ANTAGONIST; DILTIAZEM; FUREGRELATE; NIFEDIPINE; NIMODIPINE; PROSTACYCLIN; THROMBOXANE B2; VERAPAMIL;

BLOOD AND HEMOPOIETIC SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; BENZOFURANS; BLOOD PLATELETS; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DRUG SYNERGISM; EPOPROSTENOL; HUMAN; NICOTINIC ACIDS; NIFEDIPINE; NIMODIPINE; OXIDOREDUCTASES; PLATELET AGGREGATION; SUPPORT, NON-U.S. GOV'T; THROMBIN; THROMBOXANE A2; THROMBOXANE-A SYNTHASE; VERAPAMIL;

EID: 0021220777     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(84)90241-X     Document Type: Article

References (22)

1. 2+ uptake into human blood platelets
2. 2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence
3. 2
4. 2
5. Mechanism of action of calcium entry blockers
6. Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle
7. Mechanism of action of calcium channel blocking agents
8. ++-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil on platelet aggregation in vitro
9. Anti-aggregatory actions of calcium channel blockers in cat platelets
10. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil
11. The effects of nifedipine, a calcium antagonist, on platelet function
12. Inhibition of human platelet functions by verapamil
13. Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations
14. Inhibition of human platelet function by verapamil
15. Effects of verapamil on platelet aggregation, ATP release and thromboxane generation
16. In vitro effect of the coronary vasodilator diltiazem on human and rabbit platelets
17. Inhibition of platelet aggregation by verapamil: quantification by in vivo and in vitro techniques
18. Phospholipid-induced human platelet activation: effects of calcium channel blockers and calcium chelators
19. Comparison of the antithrombotic action of calcium antagonist drugs with dipyridamole in dogs
20. Effects of calcium channel blockers on arachidonate-induced sudden death in rabbits
21. Physiological disposition of verapamil in man
22. Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects